Lupus Science and Medicine podcast-logo

Lupus Science and Medicine podcast

Health & Wellness Podcasts

Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Location:

United Kingdom

Description:

Lupus Science and Medicine is a global, peer reviewed, Open Access, online journal that provides a central point for publication of basic, clinical, translational, and epidemiological studies of all aspects of lupus and related diseases. It is the first lupus-specific Open Access journal in the world and was developed in response to the need for a barrier-free forum for publication of groundbreaking studies in lupus. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Twitter:

@Lupus_SM

Language:

English


Episodes

Can you conduct clinical trials on lupus patients in a home setting?

7/2/2021
Duane Peters from the Lupus Foundation of America interviews Dr Stephen Balevic, Dr Rachel Randell and Professor Laura Schanberg from Duke University in the USA. They discuss the advantages and challenges of designing and implementing self-controlled clinical trials for paediatric lupus patients in a home setting, based on their experience of conducting the Individual Patient Exposure and Response in Pediatric Lupus (iPERSONAL) trial. Could this be a way to effectively deliver clinical...

Duration:02:16:55

EULAR 2021 eCongress Highlights

6/8/2021
Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers to discuss the highlights of the lupus research presented at the EULAR 2021 eCongress, which was held virtually on 2-5 June 2021. EULAR Congress website: https://congress.eular.org/index.cfm EULAR 2021 abstracts: https://ard.bmj.com/content/80/Suppl_1

Duration:01:04:43

Safety profile of anifrolumab in SLE patients

6/1/2021
Duane Peters from the Lupus Foundation of America interviews Professor Eric Morand from Monash University in Australia and Dr Raj Tummala from AstraZeneca in the USA about phase II and III trials of the human monoclonal antibody anifrolumab. Their pooled analysis of data from the MUSE, TULIP-1 and TULIP-2 trials showed that, in addition to demonstrating efficacy in adults with moderate to severe systemic lupus erythematosus (SLE), anifrolumab was generally well tolerated with an acceptable...

Duration:01:26:51

The ALPHA Project

5/4/2021
Duane Peters from the Lupus Foundation of America interviews Dr Susan Manzi from the Allegheny Health Network and Kathleen Arntsen from the Lupus and Allied Diseases Association, both based in the USA, about the Addressing Lupus Pillars for Health Advancement (ALPHA) Project. The ALPHA Project is the first global initiative to identify, prioritise and address top barriers in lupus impacting diagnosis, care, treatment and research. The diverse team includes lupus experts, clinicians,...

Duration:01:30:58

Lupus Academy 10th Annual Meeting Highlights

4/22/2021
Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers to discuss the highlights of the 10th Annual Meeting of the Lupus Academy, which was held virtually on 16-18th April 2021. Lupus Science & Medicine is the official journal of the Lupus Academy and the abstracts from the event have been published as a supplement to the journal. Lupus Academy website: lupus-academy.org/ Lupus Academy 2021 abstracts:...

Duration:01:17:45

Lupus Academy Tenth Annual Meeting Preview

4/8/2021
Duane Peters of the Lupus Foundation of America interviews Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers about the 10th Annual Meeting of the Lupus Academy, which will be held virtually from 16-18th April 2021. As well as his role as co-Editor-in-Chief of Lupus Science & Medicine, Professor van Vollenhoven is a member of the Lupus Academy Steering Committee and has been involved in the planning and development of the 10th Annual Meeting. Participation in the...

Duration:01:27:32

Apolipoprotein L1 risk genotypes in Ghanaian patients

4/6/2021
Duane Peters from the Lupus Foundation of America interviews Dr Ashira Blazer from New York University, USA, and Dr Ida Dzifa Dey from the University of Ghana in Accra, Ghana, about the associations between apolipoprotein L1 genetic polymorphisms and disease outcomes among SLE patients in Ghana. Access the paper here: https://lupus.bmj.com/content/8/1/e000460

Duration:00:13:15

Anti-Müllerian hormone in African- American women with SLE

3/3/2021
Duane Peters from the Lupus Foundation of America interviews Ms Meghan Angley and Dr Sam Lim from Emory University in Georgia, and Dr Megan Clowse from Duke University in North Carolina, about infertility and reproductive injustice in African-American women with systemic lupus erythematosus. Access the papers here: https://lupus.bmj.com/content/7/1/e000439 https://lupus.bmj.com/content/7/1/e000455

Duration:04:08:13

Efficacy and safety of rituximab biosimilar in refractory lupus

2/4/2021
Duane Peters from the Lupus Foundation of America interviews Dr Pintip Ngamjanyaporn and Dr Nantakarn Pongtarakulpanit from Mahidol University in Bangkok, Thailand, about their study on the short term efficacy and safety of rituximab biosimilar in refractory lupus. Access the paper here: https://lupus.bmj.com/content/7/1/e000442

Duration:01:05:19

Metabolic syndrome in SLE patients

1/6/2021
Duane Peters from the Lupus Foundation of America interviews Dr Diane Apostolopoulos and Dr Eric Morand from Monash Health in Australia about their study into the prevalence of metabolic syndrome in patients with SLE and the potential associations between the use of glucocorticoids and specific cardiovascular risk factors. Access the paper here: https://lupus.bmj.com/content/7/1/e000436

Duration:03:24:03

Validating the use of LFA-REAL to measure disease severity in SLE

12/16/2020
Duane Peters from the Lupus Foundation of America interviews Dr Manuel Francisco Ugarte-Gil from Peru and Dr Joan Merrill and Dr Anca Askanase from the USA about their study evaluating the use of LFA-REAL clinician-reported and patient-reported outcomes in establishing disease severity in SLE. Access the paper here: https://lupus.bmj.com/content/7/1/e000419

Duration:00:58:01

ANA testing in SLE and autoimmune rheumatic diseases

11/30/2020
Duane Peters from the Lupus Foundation of America interviews Dr May Choi and Dr Peter Schur from the Lupus Program at Brigham and Women's Hospital in Boston. They discuss the use of the ANA assay for the diagnosis and classification of systemic lupus and other autoimmune rheumatic diseases. Access the paper here: https://lupus.bmj.com/content/7/1/e000431

Duration:00:39:09

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue

9/2/2020
Duane Peters of the Lupus Foundation of America talks to Elisabet Svenungsson and Helena Idborg from Karolinska Institutet about their published paper: Kynurenine pathway is altered in patients with SLE and associated with severe fatigue. Access the paper here: http://doi.org/10.1136/lupus-2017-000254

Duration:01:03:47

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus

8/5/2020
Duane Peters of the Lupus Foundation of America talks to Elisabet Svenungsson and Helena Idborg from Karolinska Institutet about their published paper:TNF-alpha and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus. Access the paper here: http://doi.org/10.1136/lupus-2018-000260

Duration:01:20:59

Lupus Science & Medicine: what makes it special?

7/7/2020
Duane Peters from the Lupus Foundation of America interviews Dr Jill Buyon, Professor of Rheumatology at New York University School of Medicine and co-Editor-in-Chief of Lupus Science & Medicine. Dr Buyon presents an overview of the journal's strengths and unique features, the editorial review process, and why authors should consider submitting their next lupus paper to LSM. Learn more about the journal at lupus.bmj.com

Duration:00:16:51

Anifrolumab effects on rash and arthritis

7/1/2020
Lupus Science & Medicine Associate Editor Professor Lars Ronnblom talks to Professor Joan T. Merrill from the Oklahoma Medical Research Foundation about her published paper: Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus. Access the paper here: https://lupus.bmj.com/content/5/1/e000284

Duration:00:17:15

COVID-19 Impact on people with lupus

6/4/2020
Dr Jill Buyon, co-Editor in Chief of Lupus, Science & Medicine, explores the lessons we're learning six months into the global pandemic and the impact this is having on lupus patients, the medical landscape, and the research publishing space.

Duration:03:11:16

Lupus, immunity and Covid-19 - Part 2

4/12/2020
In the second part of a general update on the effects of Covid-19 in lupus patients, Sara Booth, University of Cambridge, talks to Dr Anca D Askanase, MD, MPH Director, Columbia University Lupus Center Associate Professor of Medicine Columbia University College of Physicians and Surgeons. Listen to part one on your favourite podcast provider, including one of the links below: https://soundcloud.com/bmjpodcasts/immunity-for-lupus-patients-and-effects-of-covid-19-part-1 Apple Podcasts:...

Duration:00:37:06

Immunity for lupus patients and effects of Covid-19 - Part 1

4/8/2020
In this podcast, Sara Booth, University of Cambridge, talks to Professor Sarah Rowlands (Florey Professor of Infection and Immunity,University of Sheffield and Honorary Consultant Physician Nuffield Department of Medicine, Oxford), who specialises in infectious diseases and has a special interest in immunity to viruses. Listen to part two on your favourite podcast provider, including one of the links below: https://soundcloud.com/bmjpodcasts/lupus-immunity-and-covid-19-part-2 Apple Podcasts:...

Duration:00:28:28

Education and the latest in treatment: reporting from the Lupus Academy 2017

6/6/2017
An insight into the important learnings of the Lupus Academy 2017 is brought to you in this special Lupus Science & Medicine podcast. The Editor-in-Chief of the journal Ronald van Vollenhoven, a founding member of the Lupus Academy, spoke with several of the faculty and the delegates during the meeting held in Lisbon, Portugal, between the 5th and the 7th of May. The Lupus Academy is a UK-based not-for-profit organisation dedicated to providing high-quality education to medical specialists...

Duration:00:12:06